Compound information
- Natural Products
- ZC2254331
- Molecular Formula
- C17H16FN3O3S
- Molecular Weight
- 361.089640592 g/mol
- Structure
-
- IUPAC Name
- 1-[(3,4-dimethoxyphenyl)methyl]-3-(6-fluoro-1,3-benzothiazol-2-yl)urea
- InChI
- InChI=1S/C17H16FN3O3S/c1-23-13-6-3-10(7-14(13)24-2)9-19-16(22)21-17-20-12-5-4-11(18)8-15(12)25-17/h3-8H,9H2,1-2H3,(H2,19,20,21,22)
- InChI Key
- UWELDSMOSDEOIG-UHFFFAOYSA-N
- SMILES
- COc1ccc(CNC(=O)Nc2nc3ccc(F)cc3s2)cc1OC
- Source
- ZINC000008328355
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 72.48 Å2 | LogP | 3.265 |
LogS | -4.608 | LogD | 3.692 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.992 | Pgp substrate | 0.507 |
HIA | 0.962 | F20 % | 0.993 |
F30 % | 0.684 | Caco-2 | -4.63 |
MDCK | -4.976 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.232 | PPB | 101.013 |
VD | 0.601 | Fu | 1.772 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.966 | CYP1A2 substrate | 0.864 |
CYP2A6 substrate | 0.683 | CYP2B6 substrate | 0.689 |
CYP2C19 inhibitor | 0.85 | CYP2C19 substrate | 0.944 |
CYP2C8 substrate | 0.894 | CYP2C9 inhibitor | 0.919 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.113 |
CYP2D6 substrate | 0.892 | CYP2E1 substrate | 0.965 |
CYP3A4 inhibitor | 0.842 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.404 | CL | 8.848 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.04 | Hepatotoxicity | 0.798 |
Mutagenicity | 0.748 | Rat Oral Acute Toxicity | 0.021 |
FDAMDD | 0.222 | Skin Sensitization | 0.12 |
Carcinogenicity | 0.743 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.281 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.917 | IGC50 | 3.517 |
LC50FM | 4.145 | LC50DM | 6.136 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.597 | NR-AR-LBD | 0.363 |
NR-AhR | 0.988 | NR-Aromatase | 0.035 |
NR-ER | 0.636 | NR-ER-LBD | 0.301 |
NR-PPAR-gamma | 0.583 | SR-ARE | 0.807 |
SR-ATAD5 | 0.784 | SR-HSE | 0.062 |
SR-MMP | 0.921 | SR-p53 | 0.716 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.